Experimental Gene Therapy Restores Hearing in About 90% of Patients in Largest Trial to Date

Key Takeaway: An experimental gene therapy for OTOF-related congenital deafness restored measurable hearing in about 90% (38 of 42) of participants in the largest trial to date. Improvements began within weeks,...



























